Brett Delahunt
Overview
Explore the profile of Brett Delahunt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
288
Citations
5509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Egevad L, Micoli C, Samaratunga H, Delahunt B, Garmo H, Stattin P, et al.
Eur Urol Oncol
. 2023 Nov;
7(2):213-221.
PMID: 37978024
Background: Since 2014, prostate cancer is reported using five-tier grouping of Gleason scores. Studies have suggested prognostic heterogeneity within the groups. Objective: We assessed the risk of prostate cancer death...
12.
Samaratunga H, Hussey D, Le Fevre I, Egevad L, Sarikwal A, Carim H, et al.
Pathology
. 2023 Oct;
56(3):413-415.
PMID: 37863712
No abstract available.
13.
Samaratunga H, Egevad L, Delahunt B
Pathology
. 2023 Oct;
56(1):141-142.
PMID: 37806944
No abstract available.
14.
Martini C, Logan J, Sorvina A, Prabhakaran S, Ung B, Johnson I, et al.
Virchows Arch
. 2023 Sep;
PMID: 37773453
No abstract available.
15.
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer
Martini C, Logan J, Sorvina A, Prabhakaran S, Ung B, Johnson I, et al.
Virchows Arch
. 2023 Sep;
485(4):723-728.
PMID: 37704825
High-grade prostatic intraepithelial neoplasia (HGPIN) is a well-characterised precursor lesion in prostate cancer. The term atypical intraductal proliferations (AIP) describes lesions with features that are far too atypical to be...
16.
Kristiansen G, Schmid M, Egevad L, Samaratunga H, Varma M, Inam K, et al.
APMIS
. 2023 Aug;
131(10):528-535.
PMID: 37620988
Only a few pathologists have the opportunity to verify their personal grading through objective assessment. This study introduces a web-based grading platform to facilitate and validate the grading of renal...
17.
Samaratunga H, Egevad L, Delahunt B
Pathology
. 2023 Aug;
55(6):903-904.
PMID: 37543492
No abstract available.
18.
Sorvina A, Martini C, Prabhakaran S, Logan J, Ung B, Moore C, et al.
Pathology
. 2023 Jul;
55(6):792-799.
PMID: 37422404
The presence of intraductal carcinoma of the prostate (IDCP) correlates with late-stage disease and poor outcomes for patients with prostatic adenocarcinoma, but the accurate and reliable staging of disease severity...
19.
Logan J, Hopkins A, Martini C, Sorvina A, Tewari P, Prabhakaran S, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370825
Gleason scoring is used within a five-tier risk stratification system to guide therapeutic decisions for patients with prostate cancer. This study aimed to compare the predictive performance of routine H&E...
20.
Samaratunga H, Egevad L, Yaxley J, Johannsen S, Le Fevre I, Perry-Keene J, et al.
Am J Surg Pathol
. 2023 Apr;
47(6):701-708.
PMID: 37057830
Anterior prostate cancer (APC) has been considered an indolent tumor, most commonly arising in the transition zone (TZ). More recently, detection of APC has been facilitated through multiparametric magnetic resonance...